| Product Code: ETC7637785 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pneumococcal Vaccine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Ireland Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Ireland Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Ireland Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Ireland Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Ireland Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for preventing pneumococcal diseases |
4.2.2 Growing initiatives by the government to promote vaccination programs |
4.2.3 Rising prevalence of pneumococcal infections in Ireland |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare services in certain regions of Ireland |
4.3.3 Vaccine hesitancy among certain population groups |
5 Ireland Pneumococcal Vaccine Market Trends |
6 Ireland Pneumococcal Vaccine Market, By Types |
6.1 Ireland Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Ireland Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Ireland Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Ireland Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Ireland Pneumococcal Vaccine Market Export to Major Countries |
7.2 Ireland Pneumococcal Vaccine Market Imports from Major Countries |
8 Ireland Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among children and elderly population |
8.2 Number of government-funded vaccination campaigns and initiatives |
8.3 Rate of reported pneumococcal infections in Ireland |
8.4 Number of healthcare facilities offering pneumococcal vaccination services |
8.5 Level of public awareness about the benefits of pneumococcal vaccination |
9 Ireland Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Ireland Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Ireland Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Ireland Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Ireland Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Ireland Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here